In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Epix Pharmaceuticals Inc.

Latest From Epix Pharmaceuticals Inc.

Jounce Therapeutics Appoints CFO

Jounce Therapeutics Inc., a company focused on novel cancer immunotherapies, has named Kim Drapkin chief financial officer (CFO). Before joining Jounce, Drapkin was the interim CFO for various biotech companies, including Jounce, through a financial consulting firm she owned. Prior to this she was CFO at EPIX pharmaceuticals and also spent 10 years at Millennium Pharmaceuticals in roles within the finance organisation.

Cancer Companies

Financings Of The Fortnight: Haircuts And Postponements Increasing As IPO Burst Slows Down

The IPO boom of 2013 is showing signs of slowing, while class of 2012 companies are seeing stock prices decline. Plus news on recent financings by Relypsa, Synta Pharmaceuticals, ArGEN-X and Karyopharm Therapeutics.

Business Strategies

Deals Of The Week Road Tests Biopharma’s Options

The industry has pulled back on experimentation with option-to-license deals; results have been mediocre and biotechs, no longer as cash-strapped as they were in 2009, when option deals peaked, have other … options. Plus deals by Roche, Endo, Pfizer, GSK and others.

BioPharmaceutical Deals

First Manhattan seeks 2nd successful life science turnaround with Vivus nominees

Activist investor First Manhattan successfully added three of its own nominees to the board of Aspect Medical Systems in 2009 and now the investment management firm wants to take over management of prescription weight-loss drug marketer Vivus by replacing all six members of the Mountain View, California-based company's board of directors.

Metabolic Disorders
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
  • Pharmaceuticals
    • Radiopharmaceuticals, Contrast Agents
  • Therapeutic Areas
  • Neurology, Nervous System
  • Respiratory, Pulmonary
  • Alias(es)
  • Metasyn
  • Epix Medical Inc.
  • Ownership
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Epix Pharmaceuticals Inc.
  • Senior Management
  • Elkan Gamzu, PhD, Pres. & CEO
    Kimberlee C Drapkin, CFO
  • Contact Info
  • Epix Pharmaceuticals Inc.
    Phone: (781) 761-7600
    4 Maguire Rd.
    Lexington, MA 02421